12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | March 06, 2023 01:31pm

Gainers

• Unicycive Therapeutics (NASDAQ:UNCY) stock moved upwards by 151.2% to $1.23 during Monday's regular session. Trading volume for this security as of 12:30 EST is 77.1 million, which is 22303.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million.
• Bellerophon Therapeutics (NASDAQ:BLPH) stock increased by 82.49% to $3.3. Bellerophon Therapeutics's stock is trading at a volume of 11.1 million shares as of 12:30 EST. This is 1023.2% of its average full-day volume over the last 100 days. The company's market cap stands at $31.4 million.
• BridgeBio Pharma (NASDAQ:BBIO) stock rose 58.0% to $17.18. Trading volume for BridgeBio Pharma's stock is 22.6 million as of 12:30 EST. This is 1535.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.5 billion.
• Ambrx Biopharma (NYSE:AMAM) shares rose 42.3% to $9.15. Trading volume for this security as of 12:30 EST is 16.5 million, which is 247.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $353.3 million.
• TCR2 Therapeutics (NASDAQ:TCRR) stock increased by 38.01% to $1.67. TCR2 Therapeutics's stock is trading at a volume of 15.1 million shares as of 12:30 EST. This is 5588.8% of its average full-day volume over the last 100 days. The company's market cap stands at $64.5 million.
• Kala Pharmaceuticals (NASDAQ:KALA) stock moved upwards by 33.37% to $22.34. As of 12:30 EST, Kala Pharmaceuticals's stock is trading at a volume of 7.2 million, which is 292.0% of its average full-day volume over the last 100 days. The company's market cap stands at $41.7 million. As per the news, the Q4 earnings report came out yesterday.

Losers

• Aclaris Therapeutics (NASDAQ:ACRS) shares fell 47.1% to $6.76 during Monday's regular session. Trading volume for Aclaris Therapeutics's stock is 10.9 million as of 12:30 EST. This is 1842.7% of its average full-day volume over the last 100 days. The company's market cap stands at $450.9 million.
• Rubius Therapeutics (NASDAQ:RUBY) shares declined by 26.83% to $0.09. As of 12:30 EST, Rubius Therapeutics's stock is trading at a volume of 10.1 million, which is 265.9% of its average full-day volume over the last 100 days. The company's market cap stands at $8.2 million.
• Adaptimmune Therapeutics (NASDAQ:ADAP) stock fell 23.87% to $1.34. Trading volume for Adaptimmune Therapeutics's stock is 3.2 million as of 12:30 EST. This is 1020.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $219.5 million. The company's, Q4 earnings came out today.
• Esperion Therapeutics (NASDAQ:ESPR) shares fell 20.43% to $5.04. As of 12:30 EST, Esperion Therapeutics's stock is trading at a volume of 11.5 million, which is 512.6% of its average full-day volume over the last 100 days. The company's market cap stands at $386.3 million.
• Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock declined by 20.35% to $5.48. Trading volume for this security as of 12:30 EST is 1.4 million, which is 39.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $52.1 million.
• Organogenesis Hldgs (NASDAQ:ORGO) stock fell 16.1% to $2.45. As of 12:30 EST, this security is trading at a volume of 1.8 million shares, making up 256.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $321.3 million. As per the press release, Q4 earnings came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRS ADAP AMAM BBIO BLPH CDIO ESPR KALA ORGO RUBY TCRR UNCY